Specifically speaking, CD44 enhances VLA-4 activity by inducing intracellular molecular pathways through binding to HA or other extracellular matrices, which in turn enhances the adhesion of leukemia cells to VCAM-1. The gene discussed is CD44; the disease is leukemia.